| Biological Sciences | Lifetime | 32 | GB 5 | 99.99 |
| Neuroscience of Neurology | Lifetime | 1 | GB 1 | 99.99 |
| Biomedical Engineering | Lifetime | 85 | GB 3 | 99.87 |
| Clinical Neurology | Lifetime | 37 | GB 9 | 99.87 |
| Cognitive Neuroscience | Lifetime | 76 | GB 16 | 99.84 |
| Speech and Hearing | Lifetime | 101 | GB 9 | 98.81 |
| History of Philosophy | Lifetime | 277 | GB 41 | 97.00 |
| Cellular and Molecular Neuroscience | Lifetime | 527 | GB 61 | 97.99 |
| Rheumatology | Lifetime | 549 | GB 53 | 97.47 |
| Rehabilitation | Lifetime | 326 | GB 40 | 95.81 |
| Neuroscience of Neurology | 2021-2025 | 23 | GB 1 | 98.72 |
| Clinical Neurology | 2021-2025 | 421 | GB 44 | 85.58 |
| Cognitive Neuroscience | 2021-2025 | 747 | GB 78 | 84.33 |
| Muscle activation and electromyography studies | Lifetime | 1 | GB 1 | 99.99 |
| Vestibular and auditory disorders | Lifetime | 1 | GB 1 | 99.86 |
| Transcranial Magnetic Stimulation Studies | Lifetime | 1 | GB 1 | 99.99 |
| Motor Control and Adaptation | Lifetime | 1 | GB 1 | 99.98 |
| EEG and Brain-Computer Interfaces | Lifetime | 7 | GB 2 | 99.91 |
| Hermeneutics and Narrative Identity | Lifetime | 4 | GB 4 | 99.24 |
| Health, Medicine and Society | Lifetime | 11 | GB 4 | 98.93 |
| Neuromodulation and Treatments for Neurological Disorders | Lifetime | 9 | GB 3 | 99.95 |
| Neuroscience and Neural Engineering | Lifetime | 18 | GB 3 | 99.83 |
| Intraoperative Neuromonitoring and Anesthetic Effects | Lifetime | 2 | GB 1 | 99.83 |
| Aging, Elder Care, and Social Issues | Lifetime | 25 | GB 13 | 98.48 |
| Glycogen Storage Diseases and Myoclonus | Lifetime | 10 | GB 4 | 99.58 |
| Stroke Rehabilitation and Recovery | Lifetime | 67 | GB 9 | 99.54 |
| Botulinum Toxin and Related Neurological Disorders | Lifetime | 51 | GB 8 | 99.54 |
| Genetic Neurodegenerative Diseases | Lifetime | 55 | GB 14 | 99.47 |
| Pain Management and Treatment | Lifetime | 24 | GB 2 | 99.03 |
| Dysphagia Assessment and Management | Lifetime | 68 | GB 6 | 98.80 |
| Parkinson's Disease Mechanisms and Treatments | Lifetime | 200 | GB 33 | 99.30 |
| Functional Brain Connectivity Studies | Lifetime | 347 | GB 49 | 99.11 |
| Autoimmune Neurological Disorders and Treatments | Lifetime | 75 | GB 13 | 97.35 |
| Neural and Behavioral Psychology Studies | Lifetime | 382 | GB 49 | 98.26 |
| Neurology and Historical Studies | Lifetime | 56 | GB 13 | 96.69 |
| Voice and Speech Disorders | Lifetime | 331 | GB 18 | 96.49 |
| Hemispheric Asymmetry in Neuroscience | Lifetime | 158 | GB 15 | 94.74 |
| Obsessive-Compulsive Spectrum Disorders | Lifetime | 494 | GB 50 | 95.79 |
| Parkinson's Disease and Spinal Disorders | Lifetime | 118 | GB 12 | 94.44 |
| Spinal Cord Injury Research | Lifetime | 620 | GB 26 | 94.38 |
| Neurological and metabolic disorders | Lifetime | 481 | GB 33 | 92.13 |
| Action Observation and Synchronization | Lifetime | 654 | GB 89 | 92.49 |
| Trigeminal Neuralgia and Treatments | Lifetime | 522 | GB 32 | 92.14 |
| Restless Legs Syndrome Research | Lifetime | 430 | GB 13 | 90.09 |
| Spatial Neglect and Hemispheric Dysfunction | Lifetime | 412 | GB 66 | 90.46 |
| Stuttering Research and Treatment | Lifetime | 649 | GB 43 | 78.88 |
| Transcranial Magnetic Stimulation Studies | 2021-2025 | 16 | GB 1 | 99.15 |
| Muscle activation and electromyography studies | 2021-2025 | 94 | GB 11 | 97.28 |
| Vestibular and auditory disorders | 2021-2025 | 59 | GB 4 | 96.31 |
| Neuromodulation and Treatments for Neurological Disorders | 2021-2025 | 530 | GB 44 | 92.33 |
| Motor Control and Adaptation | 2021-2025 | 166 | GB 16 | 88.00 |
| Botulinum Toxin and Related Neurological Disorders | 2021-2025 | 793 | GB 47 | 80.62 |
| Glycogen Storage Diseases and Myoclonus | 2021-2025 | 327 | GB 23 | 69.04 |
| Hemispheric Asymmetry in Neuroscience | 2021-2025 | 234 | GB 25 | 39.15 |
